TheProfitWatch

RNAC - Cartesian Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.16 0.08 (1.05%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.21%) --- 0.08 (1.05%) --- ---

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.51
Diluted EPS:
0.5
Basic P/E:
14.1863
Diluted P/E:
14.47
RSI(14) 1m:
53.33
VWAP:
7.24
RVol:

Events

Period Kind Movement Occurred At

Related News